Chimerix Inc (CMRX) Return on Investment ROI from the fourth quarter of 2024 to fourth quarter of 2023 and for the year 2024, average high and low, overall ranking from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Chimerix Inc   (NASDAQ: CMRX)


Chimerix Inc's ROI from its fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Chimerix Inc's ROI in the fourth quarter of 2024?
Chimerix Inc recorded a cumulative net loss of $-88 million during 12 months ending in the fourth quarter of 2024, resulting in a negative return on investment (ROI) of -59.92%.

Within the Healthcare sector 626 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2024 from 3642 to 4191.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Investment Change TTM -32.33 % -29.29 % -26.65 % -0.31 % 41.62 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 122 136 156 175 194
Return On Investment (TTM) -59.92 % -50.49 % -46.06 % -41.04 % -37.66 %
CMRX's Overall Ranking # 4191 # 3642 # 3581 # 2926 # 1860
Seq. Investment Change TTM -10.9 % -9.97 % -8.61 % -7.68 % -6.9 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -88 -84 -85 -83 -82

CMRX Company Profile >> Back to CMRX Roi Comparisons >> See Annual CMRX Return On Investment



Return On Investment CMRX's Ranking
Within: No.
Industry # 273
Sector # 627
Overall # 4191

Return On Investment Statistics
High Average Low
143.78 %
-42.19 %
-164.57 %
(Sep 30 2022)   (Jun 30 2022)







Financial Statements
Chimerix Inc's IV. Quarter Investments $ 122 Millions CMRX's Balance sheet
Chimerix Inc's IV. Quarter Income $ -23 Millions Quarterly CMRX's Income Statement
CMRX's Income by Division See CMRX's Income by Division


CMRX Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 122 194 259 71 76
Y / Y Investment Growth -37.15 % -24.95 % 266.52 % -7.28 % -30.83 %
Net Income in Millions -88 -82 172 -173 -44
Y / Y Net Income Growth - - - - -
Annual Return On Investment -72.37 % -42.24 % 66.49 % -245.22 % -57.12 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CMRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CMRX's Competitors
Subscribers only: Roi for Chimerix Inc's Suppliers
Subscribers only: Return On Investment for CMRX's Customers

Other Ratios
CMRX's Roa CMRX's Inventory Turnover Ratio CMRX's Growth Rates CMRX's Dividend Statistics
CMRX's Profitability Ratios CMRX's Asset Turnover Ratio CMRX's Dividend Growth
CMRX's Roe CMRX's Valuation Ratios CMRX's Financial Strength Ratios CMRX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2024, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.